EMPLOYMENT AGREEMENTEmployment Agreement • September 30th, 2022 • Silo Pharma, Inc. • Apparel & other finishd prods of fabrics & similar matl • New York
Contract Type FiledSeptember 30th, 2022 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into as of September 28, 2022 (the “Effective Date”), by and between Daniel Ryweck (the “Employee”) and Silo Pharma, Inc., a Delaware corporation (the “Company”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 16th, 2022 • DatChat, Inc. • Telegraph & other message communications • New York
Contract Type FiledFebruary 16th, 2022 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into as of February 15, 2022 (the “Effective Date”), by and between Brett Blumberg (the “Employee”) and DatChat, Inc., a Nevada corporation (the “Company”).
EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2021 • DatChat, Inc. • Telegraph & other message communications • New York
Contract Type FiledJuly 2nd, 2021 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into as of June 28, 2021 (the “Effective Date”), by and between Vadim Mats (the “Employee”) and DatChat, Inc., a Nevada corporation (the “Company”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • November 12th, 2019 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 12th, 2019 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”) is made and entered into as of November 12, 2019 (the “Effective Date”), by and between Jane H. Behrmann (the “Employee”) and Hoth Therapeutics, Inc., a Nevada corporation (the “Company”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 10th, 2018 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 10th, 2018 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”) is made and entered into as of [ ], 2018 (the “Effective Date”), by and between Jane H. Behrmann (the “Employee”) and Hoth Therapeutics, Inc., a Nevada corporation (the “Company”).